Neuberger Berman Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Neuberger Berman Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,708	Closed	-$1.32M	–	1856
2022 Q1	$1.32M	Sell	28,708 -4,620	-14%	-$220K	﹤0.01%	1284
2021 Q4	$2.04M	Buy	+33,328	New	+$2.3M	﹤0.01%	1188
2021 Q3	–	Sell	-2,376	Closed	-$220K	–	1762
2021 Q2	$220K	Buy	+2,376	New	+$202K	﹤0.01%	1690

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Neuberger Berman Group's ARKG Position: Q2 2022 in Review

Neuberger Berman Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 28,708 shares — an estimated $1.32M sold.

Neuberger Berman Group first reported a position in ARKG in Q2 2021 and held it in 3 quarters. The position peaked at $2.04M in Q4 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Neuberger Berman Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Neuberger Berman Group sold 28,708 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $1.32M.
Neuberger Berman Group first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 3 quarters.
Neuberger Berman Group's ARK Genomic Revolution ETF position peaked at $2.04M in Q4 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Neuberger Berman Group's 13F filing for Q2 2022, filed 15 Aug 2022.